Envestnet Asset Management Inc. Purchases 16,698 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Envestnet Asset Management Inc. raised its stake in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 5.6% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 316,489 shares of the company's stock after acquiring an additional 16,698 shares during the quarter. Envestnet Asset Management Inc. owned approximately 2.08% of U.S. Physical Therapy worth $22,901,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in USPH. GAMMA Investing LLC raised its position in shares of U.S. Physical Therapy by 27,856.8% in the first quarter. GAMMA Investing LLC now owns 12,301 shares of the company's stock valued at $890,000 after purchasing an additional 12,257 shares during the period. Lazard Asset Management LLC bought a new stake in shares of U.S. Physical Therapy in the fourth quarter valued at approximately $84,000. Wells Fargo & Company MN raised its position in shares of U.S. Physical Therapy by 2.2% in the fourth quarter. Wells Fargo & Company MN now owns 112,959 shares of the company's stock valued at $10,021,000 after purchasing an additional 2,465 shares during the period. Deutsche Bank AG raised its position in shares of U.S. Physical Therapy by 49.3% in the fourth quarter. Deutsche Bank AG now owns 13,176 shares of the company's stock valued at $1,169,000 after purchasing an additional 4,350 shares during the period. Finally, Principal Financial Group Inc. raised its position in shares of U.S. Physical Therapy by 2.3% in the first quarter. Principal Financial Group Inc. now owns 84,964 shares of the company's stock valued at $6,148,000 after purchasing an additional 1,873 shares during the period.

U.S. Physical Therapy Stock Down 1.2%

NYSE USPH traded down $0.91 during trading hours on Friday, reaching $74.04. 130,598 shares of the company's stock traded hands, compared to its average volume of 125,087. U.S. Physical Therapy, Inc. has a 52-week low of $62.77 and a 52-week high of $101.20. The firm has a market cap of $1.12 billion, a PE ratio of 33.96, a PEG ratio of 3.64 and a beta of 1.44. The firm has a 50-day simple moving average of $76.84 and a 200 day simple moving average of $78.53. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.17 and a quick ratio of 1.17.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.48 earnings per share for the quarter, beating analysts' consensus estimates of $0.46 by $0.02. The business had revenue of $183.79 million during the quarter, compared to analyst estimates of $176.78 million. U.S. Physical Therapy had a net margin of 4.57% and a return on equity of 7.89%. U.S. Physical Therapy's revenue was up 18.0% compared to the same quarter last year. During the same period last year, the business earned $0.51 EPS. Sell-side analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, June 13th. Investors of record on Friday, May 23rd were given a dividend of $0.45 per share. The ex-dividend date of this dividend was Friday, May 23rd. This represents a $1.80 annualized dividend and a yield of 2.43%. U.S. Physical Therapy's dividend payout ratio (DPR) is 82.57%.

Insider Transactions at U.S. Physical Therapy

In other U.S. Physical Therapy news, Director Nancy Ham sold 400 shares of U.S. Physical Therapy stock in a transaction that occurred on Thursday, June 12th. The shares were sold at an average price of $78.01, for a total transaction of $31,204.00. Following the transaction, the director owned 2,594 shares of the company's stock, valued at $202,357.94. The trade was a 13.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 2.00% of the company's stock.

Wall Street Analysts Forecast Growth

USPH has been the topic of a number of analyst reports. Barrington Research reaffirmed an "outperform" rating and set a $98.00 target price on shares of U.S. Physical Therapy in a report on Tuesday, July 1st. JMP Securities reissued a "market outperform" rating and issued a $113.00 price target on shares of U.S. Physical Therapy in a research note on Tuesday, April 22nd. Finally, Wall Street Zen raised shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Thursday, May 8th. Two investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, U.S. Physical Therapy presently has an average rating of "Moderate Buy" and an average price target of $109.00.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.